Echinacea tincture 50 ml.


Manufacturer: Italy

Complex treatment of acute and chronic inflammatory and purulent-infectious diseases of the mucous membranes, internal organs and skin that occur with severe intoxication and frequent relapses.



Echinacea Storage
active substance: tincture of rhizomes with roots of Echinacea purpureae radix (1:10) (extractant — ethanol 50%).

1 vial contains tinctures of rhizomes with roots of Echinacea purpureae radix (1:10) (extractant — ethanol 50%) 20 ml, 25 ml or 50 ml.

Echinacea Dosage form

Main physical and chemical properties: clear reddish-brown liquid. Sediment formation is allowed during storage.

Echinacea Pharmacotherapeutic group
Cytokines and immunomodulators. ATX code L03A X.

Pharmacological properties


The complex of active substances increases the phagocytic activity of neurophiles and macrophages, stimulates the synthesis of interleukin-1, stimulates the transformation of B-lymphocytes into plasma wedges, improves the functions of T-helpers. Inulin, lavulose and betaine improve metabolic processes, especially in the liver and kidneys. It has antiviral, antibacterial, antifungal properties.

Pharmacokinetics. Not studied.

As a part of complex treatment of immunodeficiency states at chronic recurrent inflammatory diseases of various localization. Condition after antibiotic therapy, cytostatic, immunosuppressive, radiation therapy. Initial manifestations of SARS, with long-term use of antibiotics. Local treatment of wounds that do not heal for a long time.

Hypersensitivity to the components of the drug or to plants of the family Compositae; connective tissue disease (collagenosis), multiple sclerosis and other autoimmune diseases.

Progressive systemic diseases (tuberculosis, diabetes), leukocyte diseases (leukemia, agronulocytosis), cancer, rheumatism, AIDS, HIV, systemic lupus erythematosus, immunosuppression or immunodeficiency of various etiologies and other chronic diseases.

Pregnancy or breastfeeding. Children under 12 years.

Special security measures
The duration of treatment with echinacea tincture should not exceed 8 weeks. During storage, the tincture may become cloudy and precipitate, which consists of active polysaccharides, so before taking the drug, the vial should be shaken.

Interaction with other medicinal products and other forms of interaction
Due to the immunostimulatory effect of echinacea, the drug may reduce the effectiveness of drugs that have an immunosuppressive effect.

The drug is not recommended to be used simultaneously with drugs with hepatotoxic effects, such as amiodarone, methotrexate, ketoconazole, steroids.

The drug contains ethanol, which may increase the absorption and pharmacological action of some sedative drugs and indirectly, by altering the activity of the cytochrome P450 system, affect the elimination of drugs that are metabolized by the enzymes of this system. Ethanol may cause a disulfiram-like reaction when co-administered with, for example, certain antibacterial agents.